Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Cancer Survival Analysis01:21

Cancer Survival Analysis

787
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
787
Clinical Trials: Overview01:11

Clinical Trials: Overview

5.1K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
5.1K
Clinical Trials01:16

Clinical Trials

10.9K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
10.9K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

488
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
488
Hazard Ratio01:12

Hazard Ratio

641
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
641
Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs01:20

Bioequivalence Experimental Study Designs: Completely Randomized and Randomized Block Designs

273
Body:Bioequivalence experimental study designs are crucial methodologies used in evaluating and comparing the bioavailability of different drug products. These designs are categorized into various types: completely randomized, randomized block, repeated measures, cross and carry-over, and Latin square designs.Completely randomized designs involve randomly allocating treatments to all subjects participating in the experiment. This allocation is achieved by assigning unique random numbers to...
273

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evaluation of the Efficacy of Human Papillomavirus Screening Compared With Cytology Screening in Pregnant Women: Protocol for a Prospective Multicenter Trial.

JMIR research protocols·2026
Same author

A Multicenter Phase II Study on Atezolizumab plus Bevacizumab Combination Therapy in Patients with Unresectable Hepatocellular Carcinoma and Child-Pugh Classification B Cirrhosis: CHALLENGE Trial.

Liver cancer·2026
Same author

Bayesian prior elicitation on the efficacy of medical therapies in perianal fistulizing Crohn's disease.

Journal of Crohn's & colitis·2026
Same author

Bayesian sample size determination using robust commensurate priors with interpretable discrepancy weights.

Statistical methods in medical research·2026
Same author

Covariate Adjustment in Basket Trials Borrowing Information Across Subgroups.

Statistics in medicine·2026
Same author

Clinical characteristics of and risk factors for hepatolithiasis developed after surgery for congenital biliary dilatation.

World journal of gastrointestinal surgery·2026

Related Experiment Video

Updated: Feb 19, 2026

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

11.3K

A Bayesian Treatment Selection Design for Phase II Randomised Cancer Clinical Trials.

Moka Komaki1, Satoru Shinoda2, Haiyan Zheng3

  • 1Department of Biostatistics, Doctoral Degree Program, Yokohama City University Graduate School of Medicine, Japan.

Statistics in Medicine
|February 17, 2026
PubMed
Summary

This study introduces a novel Bayesian design for Phase II cancer clinical trials, improving treatment selection efficiency and practicality. The new approach offers a flexible alternative to frequentist methods, aiding in selecting superior cancer therapies.

Keywords:
binomial dataflexible designrandomised clinical trialssample size calculationscreening design

More Related Videos

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

21.2K
Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial
03:07

Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial

Published on: August 19, 2025

1.1K

Related Experiment Videos

Last Updated: Feb 19, 2026

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition
04:53

A Clinical Trial Assessing the Safety, Efficacy, and Delivery of Olive-Oil-Based Three-Chamber Bags for Parenteral Nutrition

Published on: September 20, 2019

11.3K
Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies
08:34

Proton Therapy Delivery and Its Clinical Application in Select Solid Tumor Malignancies

Published on: February 6, 2019

21.2K
Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial
03:07

Single-Port Robotic-assisted Transaxillary Breast-conserving Surgery: A Prospective, Single-arm, Non-randomized Phase IIa Clinical Trial

Published on: August 19, 2025

1.1K

Area of Science:

  • Clinical Trials Methodology
  • Bayesian Statistics
  • Cancer Research

Background:

  • Designing efficient Phase II cancer clinical trials is critical for effective treatment selection.
  • Frequentist designs, while established, have limitations in flexibility due to fixed thresholds.
  • Bayesian approaches offer transparency and adaptability by incorporating prior knowledge and updating beliefs.

Purpose of the Study:

  • To propose a novel Bayesian design for Phase II cancer clinical trials to enhance treatment selection.
  • To develop methods for sample size determination within a Bayesian framework for these trials.
  • To provide a practical tool for clinicians to implement Bayesian designs.

Main Methods:

  • A Bayesian decision rule using posterior interval probability for binary outcomes in Phase II trials.
  • Integration of joint distribution to identify the best-performing treatment.
  • Development of two sample size determination methods for Bayesian treatment selection designs.

Main Results:

  • The proposed Bayesian design facilitates transparent decision-making for selecting the best cancer treatment.
  • Demonstrated ability to overcome sample size constraints in randomized trials through simulations and real-data applications.
  • Development of an R Shiny application for user-friendly implementation of Bayesian designs.

Conclusions:

  • The novel Bayesian methodology offers a flexible and practical approach to Phase II cancer clinical trial design.
  • The developed sample size methods support robust treatment selection under Bayesian frameworks.
  • The R Shiny application democratizes the use of advanced Bayesian designs in clinical practice, advancing cancer treatment evaluation.